Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Allergy Clin Immunol Pract ; 11(4): 1063-1067, 2023 04.
Artículo en Inglés | MEDLINE | ID: mdl-36796512

RESUMEN

Food allergy is a significant health problem affecting approximately 8% of children and 11% of adults in the United States. It exhibits all the characteristics of a "complex" genetic trait; therefore, it is necessary to look at very large numbers of patients, far more than exist at any single organization, to eliminate gaps in the current understanding of this complex chronic disorder. Advances may be achieved by bringing together food allergy data from large numbers of patients into a Data Commons, a secure and efficient platform for researchers, comprising standardized data, available in a common interface for download and/or analysis, in accordance with the FAIR (Findable, Accessible, Interoperable, and Reusable) principles. Prior data commons initiatives indicate that research community consensus and support, formal food allergy ontology, data standards, an accepted platform and data management tools, an agreed upon infrastructure, and trusted governance are the foundation of any successful data commons. In this article, we will present the justification for the creation of a food allergy data commons and describe the core principles that can make it successful and sustainable.


Asunto(s)
Recolección de Datos , Hipersensibilidad a los Alimentos , Humanos , Hipersensibilidad a los Alimentos/epidemiología , Estados Unidos/epidemiología , Difusión de la Información , Bases de Datos como Asunto , Recolección de Datos/normas
2.
J Manag Care Spec Pharm ; 25(5): 514-516, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-31039068

RESUMEN

DISCLOSURES: No outside funding supported the writing of this article. Mendez is president and CEO of the Asthma and Allergy Foundation of America, which receives greater than 25% of its funding to produce educational materials and for patient research through grants from pharmaceutical companies, including AstraZeneca, Genentech, GSK, Sanofi/Regeneron, and Teva.


Asunto(s)
Antiasmáticos/economía , Asma/tratamiento farmacológico , Análisis Costo-Beneficio/métodos , Interpretación Estadística de Datos , Modelos Económicos , Antiasmáticos/uso terapéutico , Asma/economía , Asma/mortalidad , Productos Biológicos/economía , Productos Biológicos/uso terapéutico , Centers for Medicare and Medicaid Services, U.S. , Conjuntos de Datos como Asunto , Glucocorticoides/economía , Glucocorticoides/uso terapéutico , Humanos , Revisión de Utilización de Seguros , Medición de Resultados Informados por el Paciente , Resultado del Tratamiento , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...